WO2005072050A9 - Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer - Google Patents

Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer Download PDF

Info

Publication number
WO2005072050A9
WO2005072050A9 PCT/IB2005/000433 IB2005000433W WO2005072050A9 WO 2005072050 A9 WO2005072050 A9 WO 2005072050A9 IB 2005000433 W IB2005000433 W IB 2005000433W WO 2005072050 A9 WO2005072050 A9 WO 2005072050A9
Authority
WO
WIPO (PCT)
Prior art keywords
assays
diagnosis
methods
amino acid
acid sequences
Prior art date
Application number
PCT/IB2005/000433
Other languages
French (fr)
Other versions
WO2005072050A2 (en
Inventor
Amir Toporik
Dvir Dahary
Rotem Sorek
Sarah Pollock
Zurit Levine
Pinchas Akiva
Alexander Diber
Amit Novik
Osnat Sella-Tavor
Michal Ayalon-Soffer
Shira Walach
Shirley Sameah-Greenwald
Ronen Shemesh
Naomi Keren
Maxim Shklar
Original Assignee
Compugen Usa, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Usa, Inc. filed Critical Compugen Usa, Inc.
Priority to JP2006550364A priority Critical patent/JP2007520217A/en
Priority to AU2005207882A priority patent/AU2005207882A1/en
Priority to CA002554440A priority patent/CA2554440A1/en
Priority to EP05718182A priority patent/EP1732943A4/en
Priority claimed from US11/043,842 external-priority patent/US20060183131A1/en
Publication of WO2005072050A2 publication Critical patent/WO2005072050A2/en
Publication of WO2005072050A9 publication Critical patent/WO2005072050A9/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
PCT/IB2005/000433 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer WO2005072050A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006550364A JP2007520217A (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use for breast cancer diagnosis using the same
AU2005207882A AU2005207882A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
CA002554440A CA2554440A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
EP05718182A EP1732943A4 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Applications Claiming Priority (51)

Application Number Priority Date Filing Date Title
US53912804P 2004-01-27 2004-01-27
US53912904P 2004-01-27 2004-01-27
US60/539,128 2004-01-27
US60/539,129 2004-01-27
US62100404P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US62091704P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US62065604P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US60/620,874 2004-10-22
US60/620,924 2004-10-22
US60/620,917 2004-10-22
US60/621,004 2004-10-22
US60/620,975 2004-10-22
US60/620,918 2004-10-22
US60/620,974 2004-10-22
US60/620,656 2004-10-22
US60/620,916 2004-10-22
US60/620,853 2004-10-22
US62113104P 2004-10-25 2004-10-25
US60/621,131 2004-10-25
US62012304P 2004-11-17 2004-11-17
US62823104P 2004-11-17 2004-11-17
US62817804P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US62811104P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US60/628,111 2004-11-17
US60/628,134 2004-11-17
US60/628,101 2004-11-17
US60/628,145 2004-11-17
US60/628,156 2004-11-17
US60/628,231 2004-11-17
US60/620,123 2004-11-17
US60/628,178 2004-11-17
US60/628,167 2004-11-17
US60/628,251 2004-11-17
US60/628,112 2004-11-17
US11/043,842 2005-01-27
US11/043,842 US20060183131A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
USNONE 2014-11-13

Publications (2)

Publication Number Publication Date
WO2005072050A2 WO2005072050A2 (en) 2005-08-11
WO2005072050A9 true WO2005072050A9 (en) 2010-01-14

Family

ID=34831604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000433 WO2005072050A2 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Country Status (3)

Country Link
AU (1) AU2005207882A1 (en)
CA (1) CA2554440A1 (en)
WO (1) WO2005072050A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090215042A1 (en) * 2005-06-08 2009-08-27 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
JP5299885B2 (en) * 2005-08-12 2013-09-25 学校法人日本大学 Genes related to carcinogenesis / recurrence of HCV positive hepatocellular carcinoma
CN114835812A (en) 2008-12-09 2022-08-02 霍夫曼-拉罗奇有限公司 anti-PD-L1 antibodies and their use for enhancing T cell function
GB201004551D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer

Also Published As

Publication number Publication date
CA2554440A1 (en) 2005-08-11
WO2005072050A2 (en) 2005-08-11
AU2005207882A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
IL172297A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis iii
WO2006131928A8 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2007109236A3 (en) Microrna fingerprints during human megakaryocytopoiesis
WO2007081720A3 (en) Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
HK1116249A1 (en) B7-h1 and methods of diagnosis, prognosis, and treatment of cancer b7-h1
EP1973945A4 (en) Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2005059108A3 (en) Gene expression profiles and methods of use
WO2006054297A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2007058968A3 (en) Gene expression profiles and methods of use
EP1742654A4 (en) Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer
WO2008143668A3 (en) Indoleamine-2, 3-dioxygenase-2
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
WO2005032495A8 (en) Gene expression profiles and methods of use
PT1922415E (en) Use of both rd9 and is6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets
WO2007120955A3 (en) Genes affecting human memory performance
WO2005072050A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
EP1954826A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1774046A4 (en) Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
WO2005072053A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
AU2005288710A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1732943A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2554440

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006550364

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005207882

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Country of ref document: DE

ENP Entry into the national phase

Ref document number: 2005207882

Country of ref document: AU

Date of ref document: 20050127

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005207882

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005718182

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005718182

Country of ref document: EP